The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Obecabtagene autoleucel (obe-cel, AUTO1) in adults with relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL): Overall survival (OS), event-free survival (EFS) and the potential impact of chimeric antigen receptor (CAR)-T cell persistency and consolidative stem cell transplantation (SCT) in the open-label, single-arm FELIX phase Ib/II study.
 
Elias Jabbour
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Amgen; Astellas Pharma; Bristol-Myers Squibb; Genentech; Incyte; Pfizer; Takeda
Research Funding - Abbvie; Adaptive Biotechnologies; Amgen; Ascentage Pharma Group; Pfizer; Takeda
 
Eleni Tholouli
Consulting or Advisory Role - Autolus
 
Karamjeet S. Sandhu
Consulting or Advisory Role - Autolus; Autolus
 
Paul Shaughnessy
Consulting or Advisory Role - Sanofi, Autolus
Speakers' Bureau - Sanofi, BMS
 
Pere Barba
Consulting or Advisory Role - Adicet Bio; Allogene Therapeutics; Allogene Therapeutics; Bristol-Myers Squibb/Celgene; Kite/Gilead; Kite/Gilead; Miltenyi Biomedicine; Miltenyi Biomedicine; Nektar; Nektar; Novartis; Pfizer; Pierre Fabre; Pierre Fabre
Travel, Accommodations, Expenses - Kite/Gilead; Novartis; Pfizer; Pierre Fabre; Pierre Fabre
 
Manuel Guerreiro
Expert Testimony - Novartis, Kite, BMS, MSD, Pierre Fabre
Travel, Accommodations, Expenses - Novartis, Kite, BMS, MSD, Pierre Fabre
 
Deborah Yallop
Consulting or Advisory Role - Amgen; Clinigen.; Gilead Sciences
Research Funding - Servier (Inst)
Travel, Accommodations, Expenses - Amgen; Kite/Gilead
 
Aaron Logan
Consulting or Advisory Role - Amgen; Kite, a Gilead company; Pfizer; Sanofi; Takeda
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Autolus (Inst); Kadmon (Inst); Kite, a Gilead company (Inst); Pharmacyclics (Inst); Talaris (Inst)
Travel, Accommodations, Expenses - Amgen
 
Mehrdad Abedi
No Relationships to Disclose
 
Pierre Lao-Sirieix
Employment - Autolus
Stock and Other Ownership Interests - Autolus, AstraZeneca
Patents, Royalties, Other Intellectual Property - Medtronic, Medical Research Council UK
 
Yiyun Zhang
Employment - Autolus
Stock and Other Ownership Interests - Autolus, Novartis
 
Wolfram Brugger
Employment - Autolus
Stock and Other Ownership Interests - Autolus
Travel, Accommodations, Expenses - Autolus
 
Martin A. Pule
Employment - Autolus
Stock and Other Ownership Interests - Autolus
 
Bijal D. Shah
Employment - Moffitt Cancer Center
Consulting or Advisory Role - Amgen, Pfizer, Novartis, BMS, Kite/Gilead, Precision Biosciences, Jazz, Beigene, Adaptive, Century Therapeutics, Autolus, Deciphera, Lilly, Takeda, Astra Zeneca (Inst)
Research Funding - Jazz Pharmaceuticals, Servier, Kite
Travel, Accommodations, Expenses - Kite, a Gilead Company
Other Relationship - DSMB: Pepromene Bio
 
Michael Russell Bishop
Honoraria - Bristol-Myers Squibb/Celgene/Juno; Incyte; Incyte; Sanofi/Aventis
Consulting or Advisory Role - Arcellx; Autolus; BMS; Chimeric Therapeutics; crispr therapeutics; In8Bio; Iovance Biotherapeutics; Johnson & Johnson/Janssen; Kite, a Gilead company; Novartis; Sana Biotechnology
Speakers' Bureau - Abbvie/Genmab; ADC Therapeutics; Bristol-Myers Squibb; Incyte; Kite, a Gilead company; Sanofi; SERVIER
Research Funding - Arcellx (Inst); crispr therapeutics (Inst); Iovance Biotherapeutics (Inst); Kite, a Gilead company (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - BMS; Kite/Gilead; Novartis
 
Jae H. Park
Stock and Other Ownership Interests - Curocell
Honoraria - OncLive, PER, MJH Life Sciences
Consulting or Advisory Role - Affyimmune, Allogene, Amgen, Artiva Biotherapeutics, Autolus, Be Biopharma, Beigene, Bright Pharmaceutical Services, Caribou Biosciences, Galapagos, In8Bio, Kite, Medpace, Minerva Bio, Pfizer, Servier, Sobi, Takeda
Research Funding - Genentech, Takeda, Fate Therapeutics, InCyte , Servier, Autolus (Inst)
 
Daniel J. DeAngelo
Consulting or Advisory Role - Amgen; Blueprint Medicines; Gilead Sciences; Incyte; Jazz Pharmaceuticals; Novartis; Pfizer; servier; takeda
Research Funding - Abbvie (Inst); Blueprint Medicines (Inst); glycomimetics (Inst); Novartis (Inst)
 
Karl Peggs
Employment - Achilles Therapeutics
Leadership - Achilles Therapeutics
Stock and Other Ownership Interests - Achilles Therapeutics, Autolus
Consulting or Advisory Role - Autolus, Takeda
Speakers' Bureau - Takeda
Patents, Royalties, Other Intellectual Property - Achilles Therapeutics
Travel, Accommodations, Expenses - Autolus, Takeda
 
Claire Roddie
Honoraria - Gilead Sciences
Consulting or Advisory Role - Autolus; Bristol-Myers Squibb/Celgene; Kite/Gilead
Speakers' Bureau - Gilead Sciences; Novartis Pharmaceuticals UK Ltd.
Travel, Accommodations, Expenses - Autolus; Gilead Sciences